A Phase 1 study of Tapinarof in Palmoplantar Keratoderma
Active, Not Recruiting Phase 2 NCT06561321
Study Description
Evaluating the Safety and Effectiveness of Tapinarof in Treating Thickened Skin on Palms and Soles
Study Details
- Registry ID:
- NCT06561321
- Conditions:
- Palmoplantar Keratoderma
- Phase:
- Phase 2
- Target Enrollment:
- 6 participants
- Start Date:
- Age Range:
- 18–999 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Indiana University Department of Dermatology
Indianapolis, Indiana, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.